These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 6929407)

  • 1. Biotechnology company planned.
    Newmark P
    Nature; 1980 May; 285(5761):124. PubMed ID: 6929407
    [No Abstract]   [Full Text] [Related]  

  • 2. [Initiative of the drug industry].
    el Hajj M
    Bull Cancer; 1995 Mar; 82(3):221-2. PubMed ID: 7655153
    [No Abstract]   [Full Text] [Related]  

  • 3. Private company profiles.
    Nat Biotechnol; 2003 Jul; 21 Suppl():BE23-8. PubMed ID: 12874973
    [No Abstract]   [Full Text] [Related]  

  • 4. Finding the substance behind the smoke: who is using biotechnology?
    Arunde A; Rose A
    Nat Biotechnol; 1998 Jul; 16(7):596-7. PubMed ID: 9661168
    [No Abstract]   [Full Text] [Related]  

  • 5. GeneMedix sets sight on Southeast Asia.
    Fletcher L
    Nat Biotechnol; 2001 Jan; 19(1):12. PubMed ID: 11135537
    [No Abstract]   [Full Text] [Related]  

  • 6. How will biotechnology fare in pharma's big plan?
    Nat Biotechnol; 1996 Nov; 14(11):1515. PubMed ID: 9634811
    [No Abstract]   [Full Text] [Related]  

  • 7. Patent office decision puts Genentech out in front.
    Ezzell C
    Nature; 1987 Nov 12-18; 330(6144):97. PubMed ID: 3478596
    [No Abstract]   [Full Text] [Related]  

  • 8. Around the world in a month.
    Nat Biotechnol; 2015 Sep; 33(9):896. PubMed ID: 26348948
    [No Abstract]   [Full Text] [Related]  

  • 9. Recent patent applications in microRNAs.
    Nat Biotechnol; 2006 Jan; 24(1):44. PubMed ID: 16404392
    [No Abstract]   [Full Text] [Related]  

  • 10. Gene therapy: cursed or inching towards credibility?
    Branca MA
    Nat Biotechnol; 2005 May; 23(5):519-21. PubMed ID: 15877060
    [No Abstract]   [Full Text] [Related]  

  • 11. Masters of their universe.
    Osborne R; DeFrancesco L
    Nat Biotechnol; 2009 Jun; 27(6):528-30. PubMed ID: 19513053
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cures on the cob.
    Roosevelt M
    Time; 2003 May; 161(21):56-7. PubMed ID: 12800326
    [No Abstract]   [Full Text] [Related]  

  • 13. Unlocking the money-making potential of RNAi.
    Howard K
    Nat Biotechnol; 2003 Dec; 21(12):1441-6. PubMed ID: 14647324
    [No Abstract]   [Full Text] [Related]  

  • 14. Biotechnology. French drug industry initiative.
    Anderson C
    Nature; 1991 Oct; 353(6344):487. PubMed ID: 1922346
    [No Abstract]   [Full Text] [Related]  

  • 15. Recombinant DNA Biotechnology III: The Integration of Biological and Engineering Sciences. Proceedings of a conference. Deauville, France, October 16-21, 1994.
    Ann N Y Acad Sci; 1996 May; 782():1-569. PubMed ID: 9729211
    [No Abstract]   [Full Text] [Related]  

  • 16. China's biotech is starting to bloom.
    Stipp D
    Fortune; 2002 Sep; 146(4):126-30, 132, 134. PubMed ID: 12195673
    [No Abstract]   [Full Text] [Related]  

  • 17. First Rounders Podcast: Stanley Crooke.
    Nat Biotechnol; 2015 Sep; 33(9):897. PubMed ID: 26349902
    [No Abstract]   [Full Text] [Related]  

  • 18. Plants for human health: greening biotechnology and synthetic biology.
    Moses T; Goossens A
    J Exp Bot; 2017 Jul; 68(15):4009-4011. PubMed ID: 28922776
    [No Abstract]   [Full Text] [Related]  

  • 19. The quiet revolution.
    Nat Biotechnol; 2003 Jul; 21(7):715. PubMed ID: 12833072
    [No Abstract]   [Full Text] [Related]  

  • 20. Approval times for supplemental indications for recombinant proteins.
    Gosse ME; Nelson TF
    Nat Biotechnol; 1997 Feb; 15(2):130-4. PubMed ID: 9035135
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.